Impact of treatment with immunomodulators and tumour necrosis factor antagonists on the incidence of infectious events in patients with inflammatory bowel disease

BACKGROUND: Corticosteroids, immunomodulators (IM) and tumour necrosis factor antagonists (anti-TNF) are commonly used in the treatment of inflammatory bowel disease (IBD) but they also supress the defence against infectious disease. The aim of this study was to analyse the incidence of infectious e...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersson, Per, Karling, Pontus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Academia 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788654/
https://www.ncbi.nlm.nih.gov/pubmed/35140875
http://dx.doi.org/10.48101/ujms.v127.8167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788654/
https://www.ncbi.nlm.nih.gov/pubmed/35140875
http://dx.doi.org/10.48101/ujms.v127.8167

Ejemplares similares